Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.

Werfel TA, Wang S, Jackson MA, Kavanaugh TE, Joly MM, Lee LH, Hicks DJ, Sanchez V, Ericsson PG, Kilchrist KV, Dimobi SC, Sarett SM, Brantley-Sieders DM, Cook RS, Duvall CL
Cancer Res. 2018 78 (7): 1845-1858

PMID: 29358172 · PMCID: PMC5882532 · DOI:10.1158/0008-5472.CAN-17-2388

MeSH Terms (19)

Animals Antineoplastic Agents Cell Proliferation Cell Survival Disease Models, Animal Female Humans Lapatinib Mechanistic Target of Rapamycin Complex 2 Mice Mice, Inbred BALB C Mice, Nude Nanoparticles Protein Kinase Inhibitors Rapamycin-Insensitive Companion of mTOR Protein Receptor, ErbB-2 RNA, Small Interfering Triple Negative Breast Neoplasms Xenograft Model Antitumor Assays

Connections (2)

This publication is referenced by other Labnodes entities: